International Journal of Infection Prevention invites high quality submissions that advance infection prevention, healthcare epidemiology, and antimicrobial stewardship across clinical and community settings. We welcome original research, systematic reviews, and implementation studies that reduce infection risk and improve patient safety.

Our editorial focus prioritizes rigorous study design, transparent reporting, and measurable impact on prevention practices and policy.

• Healthcare-associated infection surveillance and prevention bundles
• Antimicrobial stewardship and resistance mitigation strategies
• Outbreak investigation, response, and containment modeling
• Infection control in surgical, ICU, and long-term care settings
• Vaccination programs and implementation effectiveness
• Environmental hygiene, disinfection, and sterilization science
• WASH and community infection prevention initiatives
• Occupational exposure, PPE, and safety protocols
• Diagnostics, screening, and rapid testing workflows
• One Health approaches and zoonotic spillover prevention
• Behavior change, compliance measurement, and IPC training
• Data-driven surveillance systems and digital reporting tools

• Outbreak reports with clear response timelines
• Implementation science and quality improvement studies
• Surveillance reports and antimicrobial use analyses
• Practice or policy briefs grounded in evidence

Successful submissions present a clear prevention question, robust methodology, and transparent reporting of case definitions and denominators. We value studies that demonstrate measurable reductions in infection risk or improvements in compliance and safety.

Authors should document surveillance protocols, intervention fidelity, and outcome definitions to support reproducibility and real-world adoption.

• Clear case definitions and standardized denominators
• Validated surveillance methods and data quality checks
• Appropriate statistical analysis and handling of confounders
• Interpretation that links findings to prevention decisions

Submissions undergo editorial screening for scope fit, methodological rigor, and reporting completeness. Qualified manuscripts move to single blind peer review with subject matter experts.

IJIP operates under an open access model to ensure infection prevention research is discoverable and reusable. APCs are applied after acceptance and support peer review, production, and archiving services.

Membership options and affordable APC waivers are available for eligible authors. Contact the editorial office at [email protected] for guidance.

• Scope fit confirmed for infection prevention research
• Case definitions and denominators documented
• Data availability statement included
• Ethics approvals and consent described
• Cover letter explains novelty and prevention relevance

• Report case definitions and diagnostic criteria used for infections.
• Provide surveillance setting details, including unit type and population served.
• Define denominators for incidence rates, device days, or patient days.
• Describe infection control bundles or interventions implemented.
• Report hand hygiene measurement methods and compliance rates.
• Include antimicrobial stewardship components and audit feedback processes.
• Describe PPE protocols, training, and adherence monitoring.
• Report environmental cleaning procedures and verification methods.
• Detail sterilization and disinfection standards followed.
• Include outbreak investigation timelines and trigger thresholds.
• Report contact tracing or exposure assessment approaches when relevant.
• Describe vaccination coverage, uptake, and hesitancy metrics.
• Provide genomic surveillance methods and sequence repository links.
• Include antibiotic resistance profiles and antibiogram methodology.
• Report risk adjustment variables used in comparative analyses.
• Describe infection prevention staffing models and training programs.
• Report WASH infrastructure context for community settings.
• Include ventilation or air quality standards where applicable.
• Describe patient isolation practices and cohorting strategies.
• Report compliance audits and quality improvement cycles.
• Define outbreak control measures and escalation criteria.
• Provide health equity considerations and vulnerable population impacts.
• Include intervention fidelity monitoring and implementation barriers.
• Report data completeness checks and missing data handling.
• Describe ethical approvals and data privacy safeguards.
• Provide data availability statements and access conditions.
• State whether the study used WHO or CDC IPC guidelines.
• Describe training materials or behavior change tools used.
• Report costs, resource needs, or cost effectiveness where relevant.
• Include communication plans for outbreaks or public advisories.
• Describe interdisciplinary collaboration with laboratory teams.
• Provide primary and secondary outcome definitions.
• Report follow up durations and monitoring intervals.
• Include adverse event reporting for interventions.
• Describe pathogen transmission routes addressed by the study.
• Report screening or admission testing protocols.
• Clarify definitions for community versus healthcare associated infections.
• Include evidence of sustainability or long term adherence.
• Provide staffing or workload metrics that influence IPC outcomes.
• Describe cluster detection methods and alert thresholds used in surveillance.
• Report antimicrobial consumption metrics such as DDD per 1,000 patient days.
• Define contact precautions and isolation duration criteria applied.
• Include ventilation or air filtration parameters relevant to transmission control.
• Document environmental cleaning audits and verification tools used.
• Report staff vaccination rates or screening compliance where applicable.
• Describe patient education or signage used to reinforce IPC behaviors.
• Include outbreak communication workflows and escalation pathways.
• Report baseline infection trends and comparison periods.
• Describe PPE supply chain or access constraints that influenced implementation.
• Include adherence to WHO 5 Moments or equivalent hand hygiene standards.
• State whether isolation practices were supported by cohorting or dedicated staffing.
• Describe audit feedback loops and how findings were actioned.
• Report sustainability plans for IPC interventions beyond the study period.

IJIP is committed to rigorous, transparent publishing in infection prevention and control. We emphasize reproducible surveillance methods, clear reporting of case definitions, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in infection prevention science and implementation.